Form 4: Johnson Controls EVP and CFO, Marc Vandiepenbeeck, Reports Share Transactions

Sentiment:

SEC Form 4 Filing


Johnson Controls' EVP and CFO, Marc Vandiepenbeeck, reported the acquisition of restricted share units and employee stock options, as well as the sale of ordinary shares.

Summary

  • Marc Vandiepenbeeck, EVP and CFO of Johnson Controls, reported several transactions involving the company's stock.
  • On December 2, 2024, he acquired 9,860 restricted share units, which will vest in three equal installments over three years.
  • These restricted share units also accrue dividend equivalent units and convert to ordinary shares upon vesting.
  • Also on December 2, 2024, he was granted 33,482 employee stock options, which become exercisable in two tranches over two and three years.
  • On December 3, 2024, he sold 186 ordinary shares at a price of $83.64 per share.
  • The sale of shares was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 8, 2023.

Sentiment

Score: 6

Explanation: The document reflects routine insider transactions, which are neither particularly positive nor negative. The grants of stock options and restricted share units are positive for long-term alignment, while the small sale is neutral.

Positives

  • The grant of restricted share units and stock options to the CFO indicates a long-term incentive alignment with the company's performance.
  • The vesting schedule of the restricted share units and stock options encourages continued service and commitment from the executive.

Negatives

  • The sale of 186 ordinary shares, while small, could be interpreted as a slight reduction in the executive's direct stake in the company.

Risks

  • The vesting of restricted share units and exercisability of stock options are subject to acceleration and forfeiture provisions, which could be triggered by certain events.
  • The executive's trading activity is subject to market fluctuations and the company's performance.

Future Outlook

The restricted share units will vest in three equal installments on the first, second, and third anniversaries of the grant date. The stock options will become exercisable in two tranches on the second and third anniversaries of the grant date.

Industry Context

This filing is a routine disclosure of insider transactions and is typical for executives of publicly traded companies. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

  • The use of restricted share units and stock options as part of executive compensation is a common practice among large public companies like Johnson Controls.
  • The vesting schedules and exercise prices are generally in line with industry standards for executive compensation packages.
  • The use of a Rule 10b5-1 trading plan is a standard method for executives to manage their stock sales while avoiding accusations of insider trading.

Stakeholder Impact

  • The transactions have a minor impact on shareholders, as they reflect routine executive compensation and trading activity.
  • The vesting of restricted share units and stock options aligns the executive's interests with the long-term performance of the company.

Key Dates

DateDescription
08/08/2023Date the Rule 10b5-1 trading plan was adopted.
12/02/2024Date of restricted share unit grant and stock option grant.
12/03/2024Date of ordinary share sale.
12/04/2024Date the Form 4 was signed.
12/07/2026Date when 50% of the stock options become exercisable.
12/02/2034Expiration date of the stock options.

Keywords

insider trading, Form 4, stock options, restricted share units, executive compensation, Johnson Controls, JCI, Marc Vandiepenbeeck

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.